Bone Marrow Transplantation - Table of Contents alert Volume 49 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 49, Issue 4 (April 2014) In this issue Reviews Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement The March 2014 issue of Immunology & Cell Biology contains a special feature on NK cell recognition of unconventional ligands, featuring reviews which highlight the multifaceted roles of NK cells in detecting unconventional ligands and countering a large range of pathogens and malignancies.  Access the special feature today!    Reviews Top Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion Z Shu, S Heimfeld and D Gao Bone Marrow Transplant 2014 49: 469-476; advance online publication, September 30, 2013; 10.1038/bmt.2013.152 Abstract | Full Text Clinical guide to fertility preservation in hematopoietic cell transplant recipients S Joshi, B N Savani, E J Chow, M H Gilleece, J Halter, D A Jacobsohn, J Pidala, G P Quinn, J-Y Cahn, A A Jakubowski, N R Kamani, H M Lazarus, J D Rizzo, H C Schouten, G Socie, P Stratton, M L Sorror, A B Warwick, J R Wingard, A W Loren and N S Majhail Bone Marrow Transplant 2014 49: 477-484; advance online publication, January 13, 2014; 10.1038/bmt.2013.211 Abstract | Full Text Original Articles Top AUTOGRAFTING Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis M Magni, M Di Nicola, C Patti, R Scimè, A Mulè, A Rambaldi, T Intermesoli, P Viero, C Tarella, A Gueli, L Bergui, L Trentin, A Barzan, F Benedetti, A Ambrosetti, F Di Raimondo, A Chiarenza, G Parvis, A Billio, I Attolico, A Olivieri, M Montanari, C Carlo-Stella, P Matteucci, L Devizzi, A Guidetti, S Viviani, P Valagussa and A M Gianni Bone Marrow Transplant 2014 49: 485-491; advance online publication, January 20, 2014; 10.1038/bmt.2013.214 Abstract | Full Text ALLOGRAFTING A prospective study of lenalidomide monotherapy for relapse after Allo-SCT for multiple myeloma W I Bensinger, D J Green, N Burwick and P S Becker Bone Marrow Transplant 2014 49: 492-495; advance online publication, January 13, 2014; 10.1038/bmt.2013.219 Abstract | Full Text HLA-haploidentical hematopoietic SCT from collateral related donors without in vitro T-cell depletion for hematological malignancies Y-y Zhang, D-h Liu, K-y Liu, L-p Xu, H Chen, W Han, Y Wang and X-j Huang Bone Marrow Transplant 2014 49: 496-501; advance online publication, February 10, 2014; 10.1038/bmt.2013.223 Abstract | Full Text PEDIATRIC TRANSPLANTS Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: High incidence of endocrine and growth problems L E Cohen, J H Gordon, E Y Popovsky, S Gunawardene, E Duffey-Lind, L E Lehmann and L R Diller Bone Marrow Transplant 2014 49: 502-508; advance online publication, January 20, 2014; 10.1038/bmt.2013.218 Abstract | Full Text CONDITIONING REGIMENS Optimization of health-care organization and perceived improvement of patient comfort by switching from intra-venous BU four-times-daily infusions to a once-daily administration scheme in adult hematopoietic stem cell recipients A Xhaard, P Rzepecki, D Valcarcel, S Santarone, S Fürst, D Serrano, G De Angelis, W Krüger and C Scheid Bone Marrow Transplant 2014 49: 509-512; advance online publication, January 13, 2014; 10.1038/bmt.2013.220 Abstract | Full Text Allogeneic transplantation after reduced-intensity conditioning with fludarabine–CY for both indolent and aggressive lymphoid malignancies M J Wondergem, F S Dijkstra, O J Visser, S Zweegman, G J Ossenkoppele, B I Witte and J J W M Janssen Bone Marrow Transplant 2014 49: 513-518; advance online publication, January 13, 2014; 10.1038/bmt.2013.221 Abstract | Full Text Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy L Gao, Y Li, Y Zhang, X Chen, L Gao, C Zhang, Y Liu, P Kong, Q Wang, Y Su, C Wang, S Wang, B Li, A Sun, X Du, D Zeng, J Li, H Liu and X Zhang Bone Marrow Transplant 2014 49: 519-524; advance online publication, January 27, 2014; 10.1038/bmt.2013.224 Abstract | Full Text DONOR SELECTION Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage R N Lown, S G E Marsh, G E Switzer, K A Latham, J A Madrigal and B E Shaw Bone Marrow Transplant 2014 49: 525-531; advance online publication, January 13, 2014; 10.1038/bmt.2013.206 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD Y Inamoto, M Jagasia, W A Wood, J Pidala, J Palmer, N Khera, D Weisdorf, P A Carpenter, M E D Flowers, D Jacobsohn, P J Martin, S J Lee and S Z Pavletic on behalf of the Chronic GVHD Consortium Bone Marrow Transplant 2014 49: 532-538; advance online publication, January 27, 2014; 10.1038/bmt.2013.225 Abstract | Full Text Increased Th17/Treg ratio in chronic liver GVHD F Malard, C Bossard, E Brissot, P Chevallier, T Guillaume, J Delaunay, J-F Mosnier, P Moreau, M Grégoire, B Gaugler and M Mohty Bone Marrow Transplant 2014 49: 539-544; advance online publication, January 13, 2014; 10.1038/bmt.2013.215 Abstract | Full Text Extracorporeal photopheresis increases neutrophilic myeloid-derived suppressor cells in patients with GvHD N Rieber, I Wecker, D Neri, K Fuchs, I Schäfer, A Brand, M Pfeiffer, P Lang, W Bethge, O Amon, R Handgretinger and D Hartl Bone Marrow Transplant 2014 49: 545-552; advance online publication, January 27, 2014; 10.1038/bmt.2013.236 Abstract | Full Text INFECTIOUS COMPLICATIONS Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation M Sato, H Nakasone, K Terasako-Saito, K Sakamoto, R Yamazaki, Y Tanaka, Y Akahoshi, H Nakano, T Ugai, H Wada, R Yamasaki, Y Ishihara, K Kawamura, M Ashizawa, S-i Kimura, M Kikuchi, A Tanihara, J Kanda, S Kako, J Nishida and Y Kanda Bone Marrow Transplant 2014 49: 553-560; advance online publication, January 13, 2014; 10.1038/bmt.2013.217 Abstract | Full Text POST-TRANSPLANT EVENTS NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT K M Williams, O Hnatiuk, S A Mitchell, K Baird, S M Gadalla, S M Steinberg, J Shelhamer, A Carpenter, D Avila, T Taylor, L Grkovic, D Pulanic, L E Comis, B Blacklock-Schuver, R E Gress and S Z Pavletic Bone Marrow Transplant 2014 49: 561-566; advance online publication, January 13, 2014; 10.1038/bmt.2013.222 Abstract | Full Text Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT B Tessoulin, J Delaunay, P Chevallier, M Loirat, S Ayari, P Peterlin, S Le Gouill, T Gastinne, P Moreau, M Mohty and T Guillaume Bone Marrow Transplant 2014 49: 567-571; advance online publication, February 3, 2014; 10.1038/bmt.2013.233 Abstract | Full Text TRANSPLANT TECHNOLOGY Early CD3+/CD15+ peripheral blood leukocyte chimerism patterns correlate with long-term engraftment in non-malignant hematopoietic SCT T G Ketterl, M Flesher, R Shanley and W Miller Bone Marrow Transplant 2014 49: 572-575; advance online publication, January 13, 2014; 10.1038/bmt.2013.207 Abstract | Full Text QUALITY OF LIFE Health-related quality of life of patients with newly diagnosed chronic myeloid leukemia treated with allogeneic hematopoietic SCT versus imatinib X-D Mo, Q Jiang, L-P Xu, D-H Liu, K-Y Liu, B Jiang, H Jiang, H Chen, Y-H Chen, X-H Zhang, W Han, Y Wang and X-J Huang Bone Marrow Transplant 2014 49: 576-580; advance online publication, January 20, 2014; 10.1038/bmt.2013.232 Abstract | Full Text PSYCHOLOGICAL EFFECTS High prevalence of distress in patients after allogeneic hematopoietic SCT: Fear of progression is associated with a younger age J Hefner, M Kapp, K Drebinger, A Dannenmann, H Einsele, G-U Grigoleit, H Faller, H Csef and S Mielke Bone Marrow Transplant 2014 49: 581-584; advance online publication, January 20, 2014; 10.1038/bmt.2013.228 Abstract | Full Text Letters to the Editor Top Deferasirox improves hematopoiesis after allogeneic hematopoietic SCT G Visani, B Guiducci, C Giardini, F Loscocco, T Ricciardi and A Isidori Bone Marrow Transplant 2014 49: 585-587; advance online publication, January 13, 2014; 10.1038/bmt.2013.213 Full Text Rituximab as a treatment for factor VIII inhibitor in a patient with chronic GVHD M L Wieliczka, S Ganguly, S Abhyankar, T Lin, J P McGuirk and O S Aljitawi Bone Marrow Transplant 2014 49: 588; advance online publication, January 20, 2014; 10.1038/bmt.2013.229 Full Text Fludarabine metabolite level on day zero does not affect outcomes of hematopoietic cell transplantation in patients with normal renal function C D Griffiths, E S M Ng, S B Kangarloo, T S Williamson, M A Chaudhry, R Booker, P Duggan, P Yue, L Savoie, C Brown, N Cox-Kennett, J A Russell, A Daly and J Storek Bone Marrow Transplant 2014 49: 589-591; advance online publication, January 27, 2014; 10.1038/bmt.2013.234 Full Text Alopecia areata after HLA-identical BMT from an affected, sibling donor S Nadeem, S Hymes, P Kebriaei, L Abruzzo, J L Curry and M Duvic Bone Marrow Transplant 2014 49: 592-594; advance online publication, January 20, 2014; 10.1038/bmt.2013.212 Full Text Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report L Cudillo, E Ceresoli, L Sarmati, B Mariotti, M Viscione, A De Majo, A Di Veroli, M Andreoni and W Arcese for the Rome Transplant Network Bone Marrow Transplant 2014 49: 595-596; advance online publication, January 20, 2014; 10.1038/bmt.2013.230 Full Text Advertisement Have you read the new Cancer Gene Therapy CGT has a new editor in chief with a new vision for the journal: Steven K. Libutti, M.D. - Director of Montefiore-Einstein Center for Cancer Care - Associate Director for Clinical Services, Albert Einstein Cancer Center You can follow CGT on Twitter @cgtnature     Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.